AstraZeneca win: UK has stronger immunity than EU nations – could be better long term

AstraZeneca unveils new research centre in Cambridge

We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on our understanding. You can unsubscribe at any time. More info

Speaking to Sky News’ Kay Burley on Wednesday, Professor Paul Moss from the Institute of Immunology at the University of Birmingham said the approach used by the UK to roll out the AstraZeneca jab quickly and with specific intervals between jabs have helped the UK prevent the coronavirus waves being seen in Europe.

It comes as AstraZeneca chief executive Pascal Soriot has said the decision by other countries not to use his jab on elderly people could be why Europe is gripped by soaring infections.

Professor Moss: “We started [vaccinating] in December last year and therefore saw the waning [in infections].

“Out policy was to create a longer-term immunity during the summer and I think that has given us the benefit.”

He also noted how extending the interval between vaccine doses from three to ten-twelve weeks has given Britons “stronger immunity” against the virus.

Professor Moss noted how the AstraZeneca vaccine also gives “very strong cellular immunity”.

He emphasised how in the “long term” such immunity could be “beneficial”.

But he noted there is not quite concrete evidence in place to be sure.

Professor Moss said how the booster jab takes protection to “another level” against the virus to 93-percent.

More to follow…

Source: Read Full Article